🇺🇸 FDA
Patent

US 7074900

Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin

granted A61KA61K2035/122A61K39/35

Quick answer

US patent 7074900 (Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin) held by The Regents of the University of California expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2035/122, A61K39/35, A61P, A61P37/00